Management Change23 May 2026, 05:51 pm
Oxygenta Pharma Appoints Additional Directors, Internal Auditor
AI Summary
Oxygenta Pharmaceutical Ltd's board meeting on May 23, 2026, approved the appointment of Mr. Amireddy Venkatesu Reddy as an Additional Director (Executive category) for 3 years and Mr. Janardhana Reddy Yeddula as an Additional Director (Independent Category) for 5 years, both subject to shareholder approval. M/s. Suryachandra & Associates were appointed as Internal Auditors for FY 2026-27. The board also approved the audited financial results for the quarter and year ended March 31, 2026, and appointed M/s. Aakanksha Dubey & Co. as Scrutinizer for the e-voting process at the upcoming AGM.
Key Highlights
- Mr. Amireddy Venkatesu Reddy appointed as Additional Director (Executive) for 3 years.
- Mr. Janardhana Reddy Yeddula appointed as Additional Director (Independent) for 5 years.
- M/s. Suryachandra & Associates appointed as Internal Auditors for FY 2026-27.
- Audited financial results for the quarter and year ended March 31, 2026, approved.
- M/s. Aakanksha Dubey & Co. appointed as Scrutinizer for e-voting at the AGM.
Price Impact
More from OXYGENTAPH